Clinical Trial Update: A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessing B-701 in combination with pembrolizumab for locally advanced or metastatic urothelial carcinoma has been terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Urothelial Carcinoma
• Urinary Bladder Disease
• Urological Diseases

Drugs mentioned

• B-701
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Rainier Therapeutics | Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma, Urinary Bladder Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-03-18